Friday, 27 Mar 2020

You are here

Dr. Olga Petryna - Canakinumab in CVD Pts Prevents Acute Gout Attacks

Dr. Petryna reviews Dr. Dan Solomon's EULAR 2018 plenary presentation showing a 50-60% reduction in acute gout amongst CVD patients treated with canakinumab.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
MORE VIDEOS

A Video Collage of RheumNow Live 2019

04 Apr 2019

Dr. Sergio Schwartzman: uveitis

02 Mar 2016

Dr. David Liew: Yellow Fever...

22 Oct 2018

The RheumNow Week in Review – 9 June...

09 Jun 2017

Dr. Rachel Tate: Early Intervention for...

21 Oct 2018

Dr. Alvin Wells - Telemedicine

20 Mar 2020

Dr. Naomi Schlesinger - Complete...

15 Jun 2017

Dr. Alvin Wells - Telemedicine

20 Mar 2020

Dr. Atul Deodhar: NSAIDs in Ankylosing...

22 Oct 2018

RheumNow Podcast – Gout Spot Light (1....

11 Jan 2019

Two Particular PANLAR Gout Imaging...

18 Nov 2019

Comparison of Ixekizumab and Adalimumab...

20 Nov 2019